1-5 of 5
Lisa A Nardelli
Close
Sort by
Journal Articles

Randomized multicenter phase 2 study of pomalidomide, cyclophosphamide, and dexamethasone in relapsed refractory myeloma

Clinical Trials & Observations
Rachid C. Baz, Thomas G. Martin, III, Hui-Yi Lin, Xiuhua Zhao, Kenneth H. Shain, Hearn J. Cho, Jeffrey L. Wolf, Anuj Mahindra, Ajai Chari, Daniel M. Sullivan, Lisa A. Nardelli, Kenneth Lau, Melissa Alsina, Sundar Jagannath
Journal: Blood
Blood (2016) 127 (21): 2561–2568.
https://doi.org/10.1182/blood-2015-11-682518
Published: 2016
Includes: Supplemental data
Journal Articles

A Phase II Study to Determine the Safety and Efficacy of the Oral Inhibitor of Indoleamine 2,3-Dioxygenase (IDO) Enzyme INCB024360 in Patients with Myelodysplastic Syndromes

Rami S Komrokji, MD, Sheng Wei, MD, Adam W Mailloux, PhD, Ling Zhang, MD, Eric Padron, MD, Jeffrey E. Lancet, MD, Sara Tinsley, ARNP, Lisa A Nardelli, BS, CCRP, Cynthia Benoit, RN, Javier Pinilla-Ibarz, MD PhD, Pearlie K Epling-Burnette, PhD, Alan F List, MD
Journal: Blood
Blood (2014) 124 (21): 4653.
https://doi.org/10.1182/blood.V124.21.4653.4653
Published: 2014
Journal Articles

Pomalidomide, Cyclophosphamide, and Dexamethasone Is Superior to Pomalidomide and Dexamethasone in Relapsed and Refractory Myeloma: Results of a Multicenter Randomized Phase II Study

Rachid Baz, MD, Thomas G. Martin, MD, Melissa Alsina, MD, Kenneth H. Shain, MD PhD, Hearn J. Cho, MD PhD, Jeffrey L Wolf, MD, Anuj Mahindra, MD, Ajai Chari, MD, Daniel M Sullivan, MD, Lisa A Nardelli, BS, CCRP, Kenneth Lau, BA, Xiuhua Zhao, Hui-Yi Lin, PhD, Sundar Jagannath, MD
Journal: Blood
Blood (2014) 124 (21): 303.
https://doi.org/10.1182/blood.V124.21.303.303
Published: 2014
Journal Articles

Pomalidomide (Pom) Dexamethasone (D) With Or Without Oral Weekly Cyclophosphamide (Cy) For Lenalidomide Refractory Multiple Myeloma (LRMM): A Multicenter Randomized Phase II Trial

Rachid Baz, MD, Thomas G Martin, III, MD, Melissa Alsina, MD, Kenneth H. Shain, MD, PhD, Hearn J. Cho, MD, PhD, Jeffrey L Wolf, MD, Anuj Mahindra, M.D., Ajai Chari, MD, Daniel Sullivan, M.D., Lisa A Nardelli, BS, CCRP, Kenneth Lau, BA, Hui-Yi Lin, PhD, Sundar Jagannath, MD
Journal: Blood
Blood (2013) 122 (21): 3200.
https://doi.org/10.1182/blood.V122.21.3200.3200
Published: 2013
Journal Articles

Oral Weekly Cyclophosphamide in Combination with Pomalidomide and Dexamethasone for Relapsed and Refractory Myeloma: Report of the Dose Escalation Cohort

Rachid Baz, MD, Kenneth H. Shain, MD, PhD, Melissa Alsina, MD, Lisa A Nardelli, Taiga Nishihori, MD, Leonel Ochoa, MD, Thomas Martin, MD, Sundar Jagannath, MD, William Dalton, PhD, MD, Daniel M Sullivan, MD
Journal: Blood
Blood (2012) 120 (21): 4062.
https://doi.org/10.1182/blood.V120.21.4062.4062
Published: 2012